Investigating the patterns of treatment failure in patients with advanced stage III and IV melanoma receiving adjuvant therapy

被引：0
|
作者：
Alimohamed, Asrar Iqbal
Lawless, Aleigha
Michaud, William
Sharova, Tatyana
Rauwerdink, Daan
Dedeilia, Aikaterini
Tarantino, Giuseppe
Sade-Feldman, Moshe
Liu, David
Boland, Genevieve Marie
机构：
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Massachusetts Gen Hosp, Ctr Canc, Surg Oncol, Boston, MA USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA
[4] Dana Farber Canc Inst, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21532
引用
收藏
页数：1
相关论文
共 50 条
  • [1] EPIDEMIOLOGY, TREATMENT PATTERNS AND COSTS IN PATIENTS WITH STAGE III/IV MELANOMA
    Lugowska, I
    Szkutecka-Debek, M.
    Sozanska-Solak, A.
    Ziobro, M.
    Wysocki, P.
    Barszcz, E.
    Jakubczyk, M.
    Niewada, M.
    VALUE IN HEALTH, 2012, 15 (04) : A215 - A215
  • [2] Ipilimumab as adjuvant Therapy in Patients with Melanoma Stage IV
    Schneiderbauer, R.
    Enk, A.
    Dimitrakopoulou-Strauss, A.
    Schulz, C.
    Hassel, J. C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 47 - 47
  • [3] Where Are We With Adjuvant Therapy of Stage III and IV Melanoma in 2009?
    Fecher, Leslie A.
    Flaherty, Keith T.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2009, 7 (03): : 295 - 304
  • [4] TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH UNRESECTABLE STAGE III OR STAGE IV MELANOMA IN MEXICO
    Silva, A.
    Lazaro-Leon, M.
    de la Pena, R.
    Frausto, P.
    Vargas-Valencia, J. J.
    Gomez-Roel, X.
    Juarez-Garcia, A.
    Donato, B. M. K.
    Martinez-Rivera, G.
    Hernandez-Rivera, G.
    VALUE IN HEALTH, 2012, 15 (04) : A234 - A234
  • [5] Treatment patterns of advanced malignant melanoma (stage III-IV) - A review of current standards in Europe
    Harries, Mark
    Malvehy, Josep
    Lebbe, Celeste
    Heron, Louise
    Amelio, Justyna
    Szabo, Zsolt
    Schadendorf, Dirk
    EUROPEAN JOURNAL OF CANCER, 2016, 60 : 179 - 189
  • [6] Temozolomide (TMZ) plus thalidomide (THAL) as adjuvant therapy in patients with stage III and stage IV malignant melanoma.
    Hwu, WJ
    Coit, D
    Jaques, D
    Panageas, KS
    Lamb, LA
    Quinn, CJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 728S - 728S
  • [7] Adjuvant therapy utilization among stage III melanoma patients.
    Cowey, C. Lance
    Ghate, Sameer R.
    Rhodes, Whitney C.
    Wilson, Thomas
    Ndife, Briana
    Espirito, Janet L.
    Borker, Rohit
    Frytak, Jennifer R.
    Nakasato, Antonio Reis
    Robert, Nicholas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy
    Pedersen, Sidsel
    Holmstroem, Rikke B. B.
    von Heymann, Annika
    Tolstrup, Laerke K. K.
    Madsen, Kasper
    Petersen, Morten Aagaard
    Haslund, Charlotte A. A.
    Ruhlmann, Christina H. H.
    Schmidt, Henrik
    Johansen, Christoffer
    Svane, Inge Marie
    Ellebaek, Eva
    ACTA ONCOLOGICA, 2023, 62 (01) : 62 - 69
  • [9] TREATMENT EXPERIENCE AND PYREXIA MANAGEMENT IN A PATIENT WITH STAGE III MELANOMA RECEIVING ADJUVANT BRAF/MEK-TARGETED THERAPY
    King, Jeanelle
    McGettigan, Suzanne
    Kottschade, Lisa
    Rubin, Krista
    Madden, Kathleen
    Seery, Virginia
    ONCOLOGY NURSING FORUM, 2021, 48 (02)
  • [10] New data: adjuvant Ipilimumab-Therapy in Patients with Stage IV Melanoma
    Schneiderbauer, R.
    Enk, A.
    Buder-Bakhaya, K.
    Dimitrakopoulou-Strauss, A.
    Schulz, C.
    Hassel, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 29 - 29
12345